Regulatory Advocacy

The AAO-HNS has a long history of working closely with regulatory agencies (e.g., Centers for Medicare & Medicaid Services, U.S. Food and Drug Administration) to maintain our visibility and credibility with national representatives regarding federal regulatory issues.

We believe that advocacy is the key to defining the future of otolaryngology. Federal regulatory advocacy is a top priority of the AAO-HNS.

Final 2017 Medicare Fee Schedule
On January 5, the Academy submitted comments to Centers for Medicare & Medicaid Services (CMS) on the 2017 Medicare Physician Fee Schedule final rule. Topics addressed include: practice expense adjustments; revised global surgical data collection requirements; Appropriate Use Criteria for Advanced Diagnostic Imaging requirements; modifications to the Qualified Clinical Data Registry (QCDR) qualification requirements; and updates to the Value Based Modifier and Physician Feedback Programs. Access the comments

Academy Comments on CY 2017 HOPPS Final Rule
On December 22, the Academy submitted comments to CMS on the final rule for 2017 Hospital Outpatient Prospective Payment System (HOPPS) and Ambulatory Surgical Center Payment Rate. In the comments, the Academy addressed point-of-care imaging access for patients and changes to Ambulatory Payment Classifications assignments. Read the comments.

Academy Comments on MIPS and APM Final Rule
On December 19, the Academy submitted comments to CMS in response to the Merit-based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Final Rule. The Academy commented on the reduced reporting requirements for the transition year; MIPS performance category criteria and scoring; QCDR and quality measure reporting requirements; and applicability of APMs to Otolaryngologists - Head and Neck Surgeons. Access the comments